日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Economy

Pricing mechanism for drug firms in pipeline

By Tang Zhihao (China Daily)
Updated: 2011-03-16 11:14
Large Medium Small

BEIJING - China is likely to establish a unified pricing mechanism this year to control the prices of some pharmaceutical products included on the essential drugs list (EDL), according to a member of a drug reform commission.

Experts said the move would benefit the large domestic pharmaceutical companies and help improve the quality and safety of the nation's drugs.

Song Dacai, director of the medicine pricing section of the National Development and Reform Commission (NDRC) was quoted in the First Financial Daily as saying that EDL medicines with sufficient supply and stable market prices would be selected for the first batch of drugs to be incorporated into the new pricing system.

Song said the government hopes the pharmaceutical companies will pay more attention to improving services and the quality of their products rather than engaging in price competition. He did not reveal whether the mechanism would cover all 307 drugs on the EDL in the future.

Experts said a unified price mechanism would be quality-oriented. It would turn the attention of drug manufacturers away from simple price competition and make producers focus more strongly on combining reasonable prices with product quality and safety.

"It will be difficult for some branded pharmaceutical companies to compete with the smaller manufacturers if the government promotes the Anhui-based 'tender model'," said Guo Fanli, an analyst from the Industry Research Center at China Investment Consulting.

The Anhui-based 'tender model' was developed and used in East China last year as a means of controlling the prices of essential drugs. Under the system, those producers offering the lowest price in a bidding contest were awarded contracts to manufacture the stipulated medicines.

"The prices offered by some small drug manufacturers are so low that they would not even cover the production costs of the large manufacturers," Guo said.

Related readings:
Pricing mechanism for drug firms in pipeline Reform to offer more accessible healthcare
Pricing mechanism for drug firms in pipeline China announces 21% price cut on 162 medicines
Pricing mechanism for drug firms in pipeline Food, drug safety listed as top menu item for health experts
Pricing mechanism for drug firms in pipeline Country ramps up healthcare spending

"The model might not be helpful in improving drug quality and safety, because the bid winners might be small companies whose costs may be low, but whose products may also be substandard," said Guo.

Zhao Chao, chief executive officer of the pharmaceutical company Buchang Group, said that in the most extreme cases the price set by small companies would not even cover the packaging costs of larger companies.

Some sections of the media have reported that a number of large manufacturers have been forced to withdraw from some local markets, because they were unable to break even if they sold their products at the prices offered by the smaller players.

"We think the Anhui model may experience resistance from both the administrative body and patients," said Ding Ding, director of the research division at UBS Investment Bank.

A unified pricing system will benefit branded drug makers, according to experts. Meanwhile, it may also promote consolidation in the industry.

Larger companies may win contracts because of the higher quality of their products, but smaller producers may lose their competitive edge if a combination of quality and price is used as a basis for judgement, according to Guo.

"Companies may seek joint ventures to strengthen their position in the industry and increase market concentration."

Though officials said a unified pricing mechanism would benefit both manufacturers and patients, experts said the government should improve the monitoring process to ensure that prices are set at a reasonable level, said Guo.

The NDRC said on Monday that it would start a new round of nationwide inspections in April, and will focus on inspecting drug prices and fees for medical services.

分享按鈕
主站蜘蛛池模板: 国产激情免费 | 国产精品suv一区 | 亚洲一在线 | 国产精品va| 久久久国产精品一区二区三区 | 国产在线观看a | 国产成人综合在线观看 | 在线成人日韩 | 久久国产精品波多野结衣av | 欧美精品一二三 | 日本精品视频一区二区三区 | 久草一区二区 | 在线中文字幕视频 | 欧美aaa大片 | 超碰精品在线 | av大片在线观看 | 日韩欧美卡一卡二 | 精品视频大全 | 国产免费看av | 国产69精品久久久久久久久久 | 人人超碰人人 | 亚洲成人福利视频 | 天堂影院av | 成人免费在线视频观看 | 久久澡 | 俄罗斯毛片基地 | 婷婷色激情| 亚洲美女一区 | 日本一区二区三区四区视频 | 欧美一级做 | 波多野吉衣一区二区三区 | 国产成人综合欧美精品久久 | 夜夜夜爽 | 爱草在线 | 免费黄色国产视频 | 岛国大片在线免费观看 | 亚洲激情网站 | 国产精品福利视频 | 四虎国产成人永久精品免费 | 黄色小视频免费在线观看 | avtt天堂在线 |